NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,768 | +43.9% | 92 | +170.6% | 0.00% | – |
| Q1 2023 | $1,229 | – | 34 | +385.7% | 0.00% | – |
| Q3 2022 | $0 | – | 7 | +16.7% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 6 | -88.0% | 0.00% | – |
| Q1 2022 | $4,000 | -84.6% | 50 | -84.2% | 0.00% | -100.0% |
| Q4 2021 | $26,000 | +333.3% | 317 | +476.4% | 0.00% | – |
| Q3 2021 | $6,000 | +20.0% | 55 | -17.9% | 0.00% | -100.0% |
| Q2 2018 | $5,000 | -16.7% | 67 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $6,000 | +20.0% | 67 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $5,000 | 0.0% | 67 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $5,000 | -16.7% | 67 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $6,000 | -50.0% | 67 | -50.0% | 0.00% | 0.0% |
| Q1 2017 | $12,000 | +140.0% | 134 | +100.0% | 0.00% | 0.0% |
| Q4 2016 | $5,000 | – | 67 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |